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H I G H L I G H T S
• Suicidality is highly prevalent in autism compared to the general population.
• It is unknown whether there are validated tools to assess suicidality in autism.
• Four tools are assessed for their appropriateness and measurement properties.
• No suicidality assessment tool has been used or validated in an autistic population.
• Recommendations are made to adapt currently available tools for autistic people.
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A B S T R A C T
Adults diagnosed with autism are at signiﬁcantly increased risk of suicidal thoughts, suicidal behaviours and
dying by suicide. However, it is unclear whether any validated tools are currently available to eﬀectively assess
suicidality in autistic adults in research and clinical practice. This is crucial for understanding and preventing
premature death by suicide in this vulnerable group. This two stage systematic review therefore aimed to
identify tools used to assess suicidality in autistic and general population adults, evaluate these tools for their
appropriateness and measurement properties, and make recommendations for appropriate selection of suicid-
ality assessment tools in research and clinical practice. Three databases were searched (PsycInfo, Medline and
Web of Knowledge). Four frequently used suicidality assessment tools were identiﬁed, and subsequently rated
for quality of the evidence in support of their measurement properties using the COSMIN checklist. Despite
studies having explored suicidality in autistic adults, none had utilised a validated tool. Overall, there was lack of
evidence in support of suicidality risk assessments successfully predicting future suicide attempts. We re-
commend adaptations to current suicidality assessment tools and priorities for future research, in order to better
conceptualise suicidality and its measurement in autism.
1. Introduction
Adults diagnosed with Autism Spectrum Conditions (ASC, hereafter
autistic adults) are at high risk of experiencing suicidality compared to
other clinical groups (Cassidy et al., 2014; Hannon & Taylor, 2013;
Hedley & Uljarević, 2018; Segers & Rawana, 2014; Zahid & Upthegrove,
2017). Up to 66% of newly diagnosed adults with Asperger Syndrome
(ASC without language delay or intellectual disability) reported having
contemplated suicide, signiﬁcantly higher than the UK general popu-
lation (17%); and 35% reported that they had planned or attempted
suicide (Cassidy et al., 2014). In a large-scale population study, those
diagnosed with ASC, without co-occurring ID, were at high risk of dying
by suicide compared to the general population (Hirvikoski et al., 2016).
However, there are very few studies exploring suicidality in ASC, with
no known measures or models yet validated for this group (Cassidy &
Rodgers, 2017). Clearly, it is crucial to eﬀectively assess suicidality in
autistic adults. However, it is unclear if there are valid tools available to
assess suicidality in autistic adults, or whether existing tools need to be
adapted for this group.
ASC is characterised by diﬃculties in socialisation, imagination,
communication, narrow obsessive interests, and sensory diﬃculties
(APA, 2013). A number of characteristics of ASC may present
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challenges for clinicians in accurate identiﬁcation of suicidality in this
group. Self-injurious behaviour is commonly associated with ASC,
particularly in the context of challenging behaviour, repetitive beha-
viours and co-occurring intellectual disability (ID) (see Matson & Nebel-
Schwalm, 2007 for a review). However, there is only one study avail-
able on non-suicidal self-injury (NSSI) in autistic adults (Maddox,
Trubanova, & White, 2017). No research has yet explored whether
autistic people who present with self-injurious behaviours may be ex-
periencing suicidality or NSSI (Hannon & Taylor, 2013). This could
therefore increase risk of such behaviours being inaccurately attributed
to autism (termed diagnostic overshadowing), with suicidality not ne-
cessarily being considered.
Other characteristics of ASC may also aﬀect the utility of current
tools, which were designed for non-autistic populations, to accurately
detect suicidality in this group. For example, many autistic people tend
to interpret information literally (Happé, 1995), and experience diﬃ-
culties in ability to recall what has happened to them in the past, and
imagine what may happen to them in the future (Crane, Lind, & Bowler,
2013; Lind & Bowler, 2010). These diﬃculties could aﬀect the ability to
answer questions about lifetime suicidality, or future suicidal intent
(e.g. “How likely are you to attempt suicide someday?” Suicidal Be-
haviour Questionnaire – Revised, Osman et al., 2001). Many autistic
people also experience diﬃculty articulating their own internal emo-
tional experiences (termed alexythymia, Bird et al., 2010), which may
present diﬃculties when self-reporting on internal emotional distress in
mental health and suicidality assessments (Cassidy et al., 2014; Cassidy,
Bradley, Bowen, Wigham, & Rodgers, 2018).
There may also be unique aspects of suicidality in ASC which may
not be captured in traditional tools designed for other populations. For
example, many suicide risk assessments enquire about communication
of suicide intent to others, which is taken to indicate increased suicide
risk in the general population. However, diﬃculties in communication,
and increased chance of being isolated both in terms of access to health
services (Raja, 2014) and social connections (Orsmond, Shattuck,
Cooper, Sterzing, & Anderson, 2013) among autistic people, may lead
to lower endorsement of such items while not necessarily indicating
reduced suicide risk. Social isolation and loneliness in autistic people
and people with high autistic traits are associated with increased risk of
suicidality (Hedley, Uljarević, Wilmot, Richdale, & Dissanayake, 2018;
Pelton & Cassidy, 2017), as is lack of tangible social support (Hedley,
Uljarević, Wilmot, Richdale, & Dissanayake, 2017). Therefore it is im-
portant for clinicians as part of suicidality assessments to probe for
social isolation, loneliness and support needs in autistic people.
Checking understanding of questions in suicidality assessments, why
the person may not have told others about their suicidality (e.g. I had
no one to tell, I did not consider it important etc.), could also reveal
important information regarding risk level.
Given that the presentation of suicidality and cognitive character-
istics of ASC may impede eﬀective suicide risk assessment using tradi-
tional tools, it is crucial to identify what suicide risk assessments have
been utilised in this group, and if none are available, to identify the
most robust candidate tools in the general population to adapt. There is
a growing body of systematic reviews showing a paucity of research
exploring the measurement properties of outcome measures in ASC,
which have made important recommendations to improve research and
clinical assessment (Cassidy, Bradley, Bowen, et al., 2018; Hanratty
et al., 2015; McConachie et al., 2015; Wigham & McConachie, 2014).
These reviews have used a validated research tool developed to assess
the methodological quality of studies assessing the measurement
properties of health outcome assessment tools: the consensus based
standards for the selection of health measurement instruments
(COSMIN) (Mokkink et al., 2010; Mokkink et al., 2016; Mokkink,
Terwee, Patrick, Alonso, & Stratford, 2012). The COSMIN method in-
volves two stages. First, tools used to assess a health outcome in a well-
deﬁned population are identiﬁed from a systematic search of the lit-
erature. Subsequently, the tools used frequently (at least twice), with
evidence of validity (i.e. with reference to a previously published
study), are searched for using a comprehensive search tool validated for
this purpose (Terwee, Jansma, Riphagen, & de Vet, 2009). The quality
of the available evidence is subsequently rated using the COSMIN
checklist (Mokkink et al., 2016).
It is important to note that tools are not either valid or invalid, but
are rather valid for certain purposes or circumstances (Kamphaus &
Frick, 2005). The COSMIN checklist allows a systematic assessment of
the quality of evidence for and against a range of measurement prop-
erties, pooled across studies, thus providing a picture of the strengths
and weaknesses of the most frequently used tools in diﬀerent contexts.
This allows us to make evidence based recommendations on which tools
to select for particular clinical and/or research contexts. We therefore
utilise this robust method to identify suicidality assessment tools used
in autistic and general population adults, with similar age and in-
tellectual ability, in order to draw conclusions about the relative quality
of the evidence in each group regarding the measurement properties of
these tools. Given that autistic adults have diﬃculty accessing psy-
chiatric services due to lack of expertise and service provision for
mental health in autism (Crane, Adams, Harper, Welch, & Pellicano,
2018; Raja, 2014), suicidality assessment tools used in screening the
general population in research and clinical practice will be particularly
useful to adapt for autistic adults. The current study thus focused on
identifying suicidality screening tools used in general population
screening studies, as opposed to tools primarily used in psychiatric
groups. From this synthesis of the available evidence, we subsequently
make recommendations for future research and clinical practice aiming
to eﬀectively assess suicidality in autistic and non-autistic adults. Given
the higher risk of death by suicide in autistic adults, without ID
(Hirvikoski et al., 2016), we focused the search on adults without ID.
2. Review methods: Stage 1
The protocol for this review is registered within the International
Register of Systematic Reviews (Registration number:
CRD42016035217), and can be accessed online (http://www.crd.york.
ac.uk/PROSPERO/prospero.asp). This systematic review follows the
guidelines for Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) standards (Moher et al., 2015).
2.1. Search strategy
The following electronic bibliographic databases were searched:
Medline, PsycInfo and Web of Knowledge. The Cochrane library was
also searched to conﬁrm that no other systematic reviews of the current
study topic existed. There were two searches carried out in stage one for
suicidality measures used in; a) autistic adults, without co-occurring ID;
and b) general population adults, without any co-occurring conditions
or ID. The terms for each search strategy are included in Table 1. The
searches were restricted to peer reviewed articles published in the
English language, between 1992 and 22nd January 2018 – when the
last searches were run. The current study focused on literature per-
taining to ASC without co-occurring ID, which is frequently referred to
as Asperger Syndrome (AS). AS was ﬁrst included as a separate diag-
nosis in the WHO International Classiﬁcation of Diseases in 1992, so we
focused on studies published after this date, when we expected re-
ference to AS to be more consistent in the literature.
2.2. Selection criteria
We utilised a standardised approach to the selection of studies as in
previous COSMIN reviews (e.g. Cassidy, Bradley, Bowen, et al., 2018).
We focused on tools that include more speciﬁc (i.e. speciﬁcally sui-
cidality as opposed to self-harm or non-suicidal self-injury), and
broader (including in depth assessment of suicidality to help gauge risk
level) conceptualisations of suicidality than is feasible in single items or
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subscales. These typically fail to distinguish broader conceptualisations
of self-harm from suicidal intent, and lack information on important
risk indicators, such as current and lifetime experience, frequency, in-
tensity, intent and access to means. Therefore studies had to focus on a
tool speciﬁcally assessing suicidality, including assessment of suicidal
intent (as opposed to self-harm more generally), clinically deﬁned as in
the International Classiﬁcation of Diseases (ICD-10), and Diagnostic
and Statistical Manual of Mental Disorders (DSM-5). Studies which
utilised tools with a single suicide related question, item or subscale
contained within a larger measure (e.g. Mini-International Neu-
ropsychiatric Interview (MINI) (Hergueta, Baker, & Dunbar, 1998),
Structured Clinical Interview for DSM-IV (SCID-II) (First, Gibbon,
Spitzer, & Benjamin, 1997)), and/or without evidence of validity (i.e.
by reference to a previously published study), were excluded. This is
necessary to maximise the probability of identiﬁed tools having evi-
dence regarding their measurement properties in search two.
We searched for studies utilising tools to assess both prevalence of
suicidality (epidemiological/population studies), and assess outcomes
(treatment/intervention and longitudinal/cohort studies). To be in-
cluded studies had to focus on adults aged 18 years and over, without
ID. Where the age range was partly outside this, studies were included if
50% or more of the total population studied was over 18 years, and the
mean age of the sample was 18 years or above. This ensured that the
tools were likely to be appropriate for adults. We excluded articles
using tools which had been adapted speciﬁcally for another population
than ASC or the general population (e.g. for older adults, a particular
gender, or a speciﬁc culture). This was to ensure that the tool would
likely be useful for assessing suicidality in general population adults, as
opposed to a speciﬁc sub-group of the general population. We included
studies using the most up to date version of the tool available, as this is
most likely to be used in future research and clinical practice.
2.2.1. General population adult search criteria
Studies were included if data from general population adults,
without ID or co-occurring conditions, were presented separately, and
comprised at least 50% of the total sample. Any studies including an
autistic comparison group were excluded and considered for inclusion
in the ASC search.
2.2.2. Autistic adults search criteria
Studies were included if data from autistic adults were presented
separately, and if 50% or more of the participants had a diagnosis of
ASC.
2.3. Data extraction
One reviewer (SC) screened the titles and abstracts of articles for
inclusion, and where there was any doubt on whether an article should
be carried over to the full text sift, it was included. SC then conducted
the full text sift of articles, with any ambiguous papers discussed with
LB, EB and JR to reach consensus. All references of included articles
were also searched for additional articles to include.
Data extraction was performed by SC, and 20% of articles in-
dependently checked by LB. A data extraction form was adapted from a
previously developed form used in similar research (Cassidy, Bradley,
Bowen, et al., 2018; Wigham & McConachie, 2014). Data pertaining to:
participant characteristics, tools used, domains captured and study
type, were recorded.
3. Results: Stage 1
3.1. ASC
The search for studies using tools to assess suicidality in autistic
adults, identiﬁed 672 articles which were screened, none of which were
retained for analysis (Fig. 1). A majority of the studies initially screened
and excluded in the ASC search had explored self-injury and challen-
ging behaviour in autistic adults, often with co-occurring ID, as opposed
to suicidality – i.e. including intent to end one's own life. Crucially al-
though a limited number of studies had explored suicidality in autistic
adults, none had used a validated tool designed to assess suicidality
speciﬁcally. A majority of studies in both groups searches had utilised a
single item designed for the speciﬁc study with no evidence of validity,
or a single item or subscale contained within a larger mental health
(MINI, SCID) or depression (e.g. PHQ-9, BDI) measure. As stated above,
the current study focused speciﬁc and broader conceptualisations of
suicidality than is possible in single items or subscales. Additionally, it
is vital that there is evidence of validity of tools (e.g. by reference to a
previous study) in the ﬁrst stage, in order to identify tools which are
likely to meet COSMIN inclusion criteria in the second stage. Hence, no
studies of suicidality in ASC were identiﬁed which have used a sui-
cidality assessment tool with evidence of validity to consider further in
stage two.
3.2. General population
The search for studies using tools to assess suicidality in general
population adults identiﬁed 1774 articles which were screened, with 25
retained for analysis (Fig. 1). Fourteen diﬀerent tools were used to as-
sess suicidality in the studies (Appendix A). Self-report questionnaires
included: Columbia Suicide Severity Rating Scale (C-SSRS) (Posner
et al., 2011), Measure of Episodic Planning of Suicide (MEPOS)
(Anestis, Pennings, & Williams, 2014), Suicide Behaviours Ques-
tionnaire Revised (SBQ-R) (Osman et al., 2001), Beck Scale for Suicidal
Ideation (BSS) (Beck, Steer, & Ranieri, 1988), Beck Suicide Intent In-
ventory (BSI) (Beck, Schuyler, & Herman, 1974), Depression Severity
Index – Suicide Subscale (DSI-SS) (Metalsky & Joiner, 1997), Modiﬁed
Scale for Suicidal Ideation (MSSI) (Miller, Norman, Bishop, & Dow,
1986), Paykel (Paykel, Myers, Lindenthal, & Tanner, 1974), Sheehan
Suicidality Tracking Scale (S-STS) (Coric, Stock, Pultz, Marcus, &
Sheehan, 2009), Suicide Assessment Scale (SUAS-S) (Stanley,
Träskman-Bendz, & Stanley, 1986), Suicide Ideation Scale (SIS) (Rudd,
1989), Suicide Score Scale (SSS) (Innamorati, Pompili, Lester, Tatarelli,
& Girardi, 2008a), and the Plutchik Suicide Risk Scale (PSRS) (Aradilla-
Herrero, Tomás-Sábado, & Gómez-Benito, 2014). The searches also
identiﬁed clinician interview versions of the Columbia Suicide Severity
Rating Scale (C-SSRS) (Posner et al., 2011), Beck Suicide Intent
Table 1
Stage 1 review search terms.
1. (General population or population sample or community sample or
national⁎survey or household⁎survey or non referred or non clinical or
population screen⁎)
2. (ASC or ASD or Asperg⁎or Autis⁎or high functioning or pervasive
developmental disorder⁎or PDD or HFA)
3. (Adult⁎)
4. (Assess⁎or tool or treatment outcome or measur⁎or scale or quotient or
inventory or instrument)
5. (Suicid⁎or self harm or self inj⁎or parasuicide or suicide attempts or
attempted suicide)
6. Randomized controlled trial or randomized controlled trial
7. Random⁎
8. Comparative stud⁎
9. Prospective stud⁎
10. Intervention
11. Treatment eﬀectiveness evaluation or treatment response or treatment
study
12. Epidemiolog⁎
13. Prevalence
14. General Population Search (6 or 7 or 8 or 9 or 10 or 11 or 12 or 13) and (1 and
3 and 4 and 5)
15. Autism Spectrum Condition Search (6 or 7 or 8 or 9 or 10 or 11 or 12 or 13) and
(2 and 3 and 4 and 5)
16. Limit 14 and 15 to English Language; 1992 – current; age 18 years +
⁎ Denotes wildcard search terms.
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Inventory (BSI) (Beck et al., 1974), Paykel (Paykel et al., 1974),
Sheehan Suicidality Tracking Scale (S-STS) (Coric et al., 2009), and the
Self-Injurious Thoughts and Behaviours Interview (SITBI) (Nock,
Holmberg, Photos, & Michel, 2007). Eight of these tools had each only
been used in one study in the general population, without co-morbid
conditions (MEPOS; BSI; DSI-SS; MSSI; S-STS; SUAS-S; SIS; and SSS).
Therefore these tools were not considered further, as we were interested
in tools which had been used frequently (at least twice) in the general
population with some evidence of validity, to maximise the chances of
there being evidence available to evaluate using the COSMIN checklist.
Hence, ﬁve tools (C-SSRS; SBQ-R; BSS; SITBI and Paykel) were con-
sidered further in stage 2.
4. Review methods: Stage 2
The second stage of the review searched for evidence of the mea-
surement properties of the tools identiﬁed in stage 1. In order to do this,
a comprehensive search was carried out using a methodological ﬁlter in
PubMed, designed to search for studies assessing the measurement
properties of health outcome assessment tools (Terwee et al., 2009). We
focused on studies which had explored the measurement properties of
the tools in adults (18 years and over), without co-occurring ID. Unlike
in stage 1, Adult samples with co-occurring conditions were included,
as suicidality assessment tools used frequently in the general population
may nevertheless be validated in psychiatric samples. Including studies
of clinical samples thus provides useful information regarding the
contexts the tools may be most useful in research and/or clinical
practice.
4.1. Data extraction method
Once articles were identiﬁed from the search, the methodological
quality of each article was assessed using the COSMIN checklist
(Consensus based Standards for the selection of health based mea-
surement Instruments) (Mokkink et al., 2016). COSMIN rates the evi-
dence in support of 9 measurement properties on a 4-point scale (from
excellent to poor): internal consistency, reliability, measurement error,
content validity, structural validity, hypothesis testing, criterion va-
lidity, responsiveness to change, and cross cultural validity. COSMIN
implements a ‘worst score counts’ method, by which an overall rating is
assigned to each measurement property based on the lowest score
provided. For example, if a study is rated excellent on all criteria related
to internal consistency (e.g. Cohen's Kappa was calculated, an adequate
sample size was utilised etc.), but the study failed to check the uni-
dimensionality of the scale, then this study would still be rated as ‘poor’
overall (Mokkink et al., 2010).
The checklists were completed by SC, with 9 (34.6%) of the articles
independently rated by SW, both of whom were trained and experi-
enced in using COSMIN. Inter-rater reliability between SC and SW was
73%, similar to previous studies (e.g. Cassidy, Bradley, Bowen, et al.,
2018; Wigham & McConachie, 2014). Disagreements were resolved
with discussion and these agreed COSMIN ratings were utilised in the
subsequent evidence synthesis.
4.2. Evidence synthesis
The quality of the evidence in support of each measurement
Fig. 1. Results of search one.
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property needs to be considered in the context of the studies' ﬁndings,
in order to gauge the amount of evidence available for or against each
measurement property. First, the quantitative ﬁndings from each study
are given a rating of positive (in support of the property), indeterminate
(not possible to deduce whether the evidence is for or against the
property), or negative (evidence against the property). For example,
criterion validity is considered positive when the study supplies con-
vincing evidence that the criterion used is indeed a gold standard, and
the correlation between the outcome measure and the gold standard
criterion is> 0.7 (De Vet, Terwee, Mokkink, & Knol, 2011). Subse-
quently, the quality of the evidence is considered in the context of the
studies quantitative ﬁndings. Strong evidence (+++/−−−) is de-
ﬁned as one methodologically excellent or several good studies which
ﬁnd consistent evidence for or against a measurement property; mod-
erate evidence (++/−−) is deﬁned as one methodologically good or
several fair studies which ﬁnd consistent evidence for or against a
measurement property; limited evidence (+/−) is deﬁned as one
methodologically fair study ﬁnding evidence for or against a mea-
surement property; conﬂicting evidence (+/−) is where the evidence
for or against a measurement property is not consistent between stu-
dies; and indeterminate evidence (?), is where there are only studies of
poor methodological quality available for a measurement property
(Mokkink et al., 2012).
4.3. Results: Stage 2
The PubMed search for studies assessing the measurement proper-
ties of suicidality tools used in general population adults identiﬁed 218
articles which were screened, 26 of which were retained for analysis
(Fig. 2) (see Appendix B for characteristics of the study populations
included in the analysis).
No articles assessing the measurement properties of the Paykel were
identiﬁed from the search. The methodological quality of the included
studies is presented in Table 2 and the collated evidence pertaining to
the measurement properties for each tool are presented in Table 3.
Many of the articles reported data on diﬀerences in scores and nor-
mative data, which are important for interpretability (De Vet et al.,
2011). However, no studies reported minimal important change or ﬂoor
or ceiling eﬀects.
4.3.1. Suicide Behaviour Questionnaire – Revised (SBQ-R)
Despite evidence of being widely used in general population studies
of suicidality, only two studies were found assessing the measurement
properties of the SBQ-R in adults. The quality of the evidence in support
of hypothesis testing was weak, with one fair study showing signiﬁcant
diﬀerences between psychiatric and non-clinical populations in line
with hypotheses with large eﬀect (Osman et al., 2001). The quality of
the evidence in support of criterion validity was moderate: sensitivity
(> 0.882) and speciﬁcity (> 0.875) were acceptable for successfully
diﬀerentiating suicidal from non-suicidal individuals, using both the
ﬁrst item of the SBQ-R (Aloba, Ojeleye, & Aloba, 2017) and total scores
(Aloba et al., 2017; Osman et al., 2001). The quality of the evidence for
internal consistency was strong, with one excellent study showing ac-
ceptable Cronbachs alpha (0.8) for the whole scale, conﬁrmed as uni-
dimensional via factor analysis (Aloba et al., 2017). Evidence for
structural validity was also strong, with one excellent study showing
support for a one-factor solution (Aloba et al., 2017).
4.3.2. Beck Scale for Suicide Ideation (BSS)
The measurement properties of the BSS have primarily been as-
sessed in psychiatric patient samples, despite being used in many
general population studies. The evidence in support of hypothesis
testing was mixed. One study showed weak evidence against the BSS
predicting future adverse events (e.g. future suicide attempts) (de
Beurs, Fokkema, & O'Connor, 2016), and one poor study (Cochrane-
Brink, Lofchy, & Sakinofsky, 2000, due to the small sample size)
showed evidence in support of the BSS predicting future adverse events.
However, there was moderate evidence for the BSS signiﬁcantly cor-
relating with other relevant measures and demographics (Esfahani,
Hashemi, & Alavi, 2015; Horon et al., 2013; Kliem, Lohmann, Mößle, &
Brähler, 2017; Cochrane-Brink et al., 2000), moderate evidence for
factors remaining consistent over time (de Beurs, Fokkema, de Groot,
de Keijser, & Kerkhof, 2015), and strong evidence for the BSS distin-
guishing subgroups (e.g. suicide attempters vs. non-attempters) (Horon
et al., 2013; Healy, Barry, Blow, Welsh, & Milner, 2006; Pinninti, Steer,
Rissmiller, Nelson, & Beck, 2002).
The evidence in support of criterion validity for the BSS was simi-
larly mixed. One excellent study (de Beurs et al., 2016) showed low
speciﬁcity (0.2) but high sensitivity (0.95) for the BSS predicting future
suicidal behaviour, a good study (Chang & Tan, 2015) showed a poor
AUC (<0.44) for predicting future adverse events and a poor study
(due to small sample size) showed excellent sensitivity (100%) and
speciﬁcity (90%) for predicting future hospitalisations (Cochrane-Brink
et al., 2000). However, there was consistent strong evidence for high
sensitivity and speciﬁcity when distinguishing clinical groups (Horon
et al., 2013; Pinninti et al., 2002; Cochrane-Brink et al., 2000) (e.g.
hospitalised vs. non-hospitalised; multiple, single or no previous suicide
attempts).
The evidence in support of internal consistency for the BSS was
strong, with one excellent study showing high internal consistency in a
translated version of the BSS (Esfahani et al., 2015). Evidence in sup-
port of reliability of the BSS was indeterminate, with two studies of
poor methodological quality - observations were not independent
(Healy et al., 2006), or sample size was small with patients undergoing
treatment between measurements (Pinninti et al., 2002). The evidence
in support of structural validity for the BSS was strong (de Beurs et al.,
2015; Esfahani et al., 2015; Holden and DeLisle, 2005; Steer, Rissmiller,
Ranieri, & Beck, 1993). Two studies assessed cross-cultural validity of
the BSS. The quality of the translations were fair (with one back and
forward translation), giving moderate evidence in support of the BSS
cross-cultural validity (Ayub, 2008; Esfahani et al., 2015).
4.3.3. Columbia suicide severity rating scale (C-SSRS)
Most studies of the C-SSRS explored the measurement properties of
the clinician interview version (7/11 studies). There was mixed evi-
dence for internal consistency: two studies showed high Cronbach's
alpha for the whole measure (Madan et al., 2016; Posner et al., 2011),
but not on some subscales (Madan et al., 2016), and another study
showed a poor alpha (Al-Halabí et al., 2016). There was mixed evidence
for reliability: one fair study showed a large range of inter-rater relia-
bility (r= 0.5–0.9) (Youngstrom et al., 2015), but two poor studies
with small samples showed high agreement between raters (0.9+)
(Hesdorﬀer et al., 2013; Mundt et al., 2010). The evidence in support of
structural validity was strong (Madan et al., 2016; Al-Halabí et al.,
2016), as was the evidence in support of criterion validity, and mod-
erate evidence in support of hypothesis testing (Al-Halabí et al., 2016;
Hesdorﬀer et al., 2013; Horwitz, Czyz, & King, 2015; Madan et al.,
2016; Mundt et al., 2010; Posner et al., 2011). It is also important to
note that one of these studies rated as ‘good’, showed that the C-SSRS
had acceptable speciﬁcity and sensitivity (> 0.7) for predicting future
adverse events 6months after discharge (Madan et al., 2016). Evidence
for responsivity to change was moderate, with two fair studies (Al-
Halabí et al., 2016; Posner et al., 2011). One fair study found weak
evidence in support of cross-cultural validity (Al-Halabí et al., 2016).
Four studies explored the measurement properties of the C-SSRS
self-report version. There was weak evidence against hypothesis testing,
with one fair study showing a poor correlation with the S-STS (Sheehan
et al., 2014). There was mixed evidence for criterion validity: one good
study showed high speciﬁcity and sensitivity with clinical assessment
(Viguera et al., 2015); one fair study showed evidence against the
measure with poor agreement with the S-STS (Sheehan et al., 2014),
and another good study showed evidence against the measure with
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poor prediction of future adverse events (Chang & Tan, 2015).
4.3.4. Self-Injurious Thoughts and Behaviours Interview (SITBI)
One study had explored measurement properties of the translated
Spanish version of the SITBI in 150 inpatients (García-Nieto, Blasco-
Fontecilla, Yepes, & Baca-García, 2013). Evidence for inter-rater relia-
bility was poor given the small subsample in which this was assessed
(n=15), but in support of the measure with near perfect agreement
between raters (k= 0.09–1). Evidence for test retest reliability was fair,
but against the measure with poor reliability for suicidal gestures and
self-harm. Evidence for hypothesis testing was fair, but against the
measure with poor agreement with certain measures of similar con-
structs. Evidence for cross-cultural validity was poor, with only a for-
ward translation carried out.
5. Discussion
Although research shows high rates of suicidality (Cassidy et al.,
2014) and death by suicide in autistic adults (Hirvikoski et al., 2016), it
was unknown whether any suicidality assessment tools had been used
or validated in this group, or whether a robust tool developed for the
general population needed to be adapted. Results from this review show
that despite studies having explored suicidality in autistic adults
without ID, no research has yet used a validated suicidality assessment
tool in this group. This is consistent with the growing body of COSMIN
reviews showing a paucity of validated outcome measures for autistic
people (Cassidy, Bradley, Bowen, et al., 2018; Hanratty et al., 2015;
Wigham & McConachie, 2014). These results are an important call to
action for the research community, to improve the characterisation of
outcomes and their measurement in ASC, in research and clinical
practice.
Studies of suicidality in ASC were found to utilise a question gen-
erated for use in the speciﬁc study, without evidence of validity, or used
a single question or brief subscale from a broader mental health mea-
sure (e.g. PHQ-9, BDI, MINI, SCID). This may reﬂect the fact that cur-
rently many studies of suicidality in ASC have utilised convenience
samples from clinical settings, wider studies and existing databases.
This lack of standardised and in depth assessment is problematic. For
example, single questions from depression measures such as the PHQ-9
do not distinguish self-harm from suicidal intent, and therefore do not
assess suicidality per se. The range of measures, many of which lack
evidence of validity, could also explain, at least in part, the wide range
of suicidality estimates cited in recent reviews of suicidal ideation
(11–66%) and attempts (1–35%) in ASC (Hedley & Uljarević, 2018). A
clear recommendation for future suicidality in ASC research is to start
using suicidality assessment tools with high quality evidence in support
of their measurement properties, in line with the recommendations of
COSMIN (Mokkink et al., 2016). We make recommendations on future
selection of such tools based on our synthesis of the available evidence
below.
Fig. 2. Results of search two.
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A number of validated suicidality assessment tools have been used
frequently in studies of general population adults, without ID or co-
occurring conditions; the SBQ-R, C-SSRS, BSS, Paykel and SITBI.
Interestingly, no studies were revealed from the comprehensive search
that had assessed the measurement properties of the Paykel, despite it
being utilised in a number of research studies. The C-SSRS and BSS had
also been validated mainly in psychiatric samples despite being used in
a number of general population studies. Importantly, although the
evidence for hypothesis testing and criterion validity was mixed for the
BSS, this clearly depended on the context in which this tool was used.
Speciﬁcally, the BSS had strong evidence in support of distinguishing
sub-groups (e.g. those who have and have not attempted suicide), but
strong evidence against predicting future adverse events (e.g. hospital
admissions for suicide attempt). The BSS also had strong evidence for
internal consistency, structural validity, and moderate evidence for
cross-cultural validity. Hence, the strengths of the BSS lie in distin-
guishing sub groups in research, but not when predicting future adverse
events in clinical practice.
Two versions of the C-SSRS were assessed; the self-report and clin-
ician interview versions. The self-report version has been more recently
developed, and therefore fewer studies (4) were available assessing its
measurement properties than the clinician interview version (7). For
the self-report C-SSRS, there was weak evidence against hypothesis
testing, and mixed evidence for criterion validity. Speciﬁcally, there
was moderate evidence in support of agreement between the C-SSRS
self-report and clinician assessment (Viguera et al., 2015), but moderate
evidence against the C-SSRS self-report predicting future adverse events
(Chang & Tan, 2015). Currently, there is not yet enough evidence to
recommend this tool for use in research or clinical practice.
However, the clinician interview version of the C-SSRS had evidence
in support of a number of measurement properties. The strengths of the
measure lie in structural validity, hypothesis testing, criterion validity
and responsiveness to change, and weak evidence in support of cross-
cultural validity. Importantly, there was moderate evidence in support
of the C-SSRS predicting future suicidal behaviour within 6months of
discharge (Madan et al., 2016). There was however mixed evidence for
internal consistency and reliability. This suggests that the clinician in-
terview version of the C-SSRS is likely to be most useful in clinical
contexts, to aid clinicians in helping to gauge potential suicide risk as
part of a holistic psychosocial assessment, and changes in response to
treatment or within clinical trials. However, more research is needed to
establish evidence in support of inter-rater agreement, and internal
consistency, particularly concerning subscales.
There was only one study that had explored the measurement
properties of the SITBI in adults without ID (with one additional vali-
dation study in an adolescent sample which was not included) (García-
Nieto et al., 2013). Hence there was limited evidence in support of its
measurement properties. Notably, the study showed evidence against
hypothesis testing with low agreement with measures of similar con-
structs. Future research needs to establish the measurement properties
of this tool.
There were only two studies exploring the measurement properties
of the SBQ-R, despite being used in a number of general population
studies of suicidality. Despite this, there was strong evidence in support
of internal consistency and structural validity, moderate evidence in
support of criterion validity, and weak evidence in support of hypoth-
esis testing. In particular, the SBQ-R showed evidence for high sensi-
tivity and speciﬁcity for distinguishing sub-groups using the ﬁrst item
(Aloba et al., 2017) and total scores (Aloba et al., 2017; Osman et al.,
2001). Notably, the SBQ-R is the briefest tool out those identiﬁed in this
review (with 1–4 items), does not carry a cost to use, and has com-
parable quality of evidence in support of a range of measurement
properties compared to the other scales which are longer and carry a
cost (C-SSRS and BSS). Hence, the SBQ-R could be particularly useful
for future research.
In summary, the current study revealed strong consistent evidence
across three frequently used suicidality assessment tools (BSS, C-SSRS
and SBQ-R), for reliably distinguishing sub-groups (e.g. those who have
or have not attempted suicide in the past). However, there were rela-
tively few studies exploring an important component of criterion va-
lidity for suicidality assessment tools – prediction of future adverse
events (e.g. future suicidal behaviour, future hospitalisations or emer-
gency department visits). Research has suggested that suicidality as-
sessment tools on the whole are poor predictors of future attempts,
many perform worse than patient or clinical assessment, and may
therefore be a waste of valuable resources (Quinlivan et al., 2016;
Quinlivan et al., 2017). The current study adds useful evidence to this
debate, as it is the ﬁrst to use a validated research tool (COSMIN), to
synthesise the quality of the evidence for a range of measurement
properties, across a number of studies. On the basis of our synthesis of
the available evidence, results suggest that certain tools (i.e. C-SSRS
interview) may have greater utility in predicting future adverse events
than others (e.g. BSS). Results also suggest that designs which assess
criterion validity on the basis of distinguishing sub-groups may over-
estimate diagnostic accuracy of a tool. This is consistent with previous
research (Lijmer et al., 1999), which recommends the use of cohort
studies in assessing the usefulness of suicidality assessment tools.
5.1. Future research
No studies have yet utilised any of the suicidality assessment tools
that have been developed for and widely used in the general popula-
tion, in autistic adults. As discussed above, the characteristics of ASC,
and diﬀering presentation of suicidality in this group, could all aﬀect
the utility of these tools. A ﬁrst step would be to explore the content
validity of these existing tools through focus groups and cognitive in-
terviews, to inform adaptations, prior to exploring other measurement
properties of these tools. COSMIN criteria stipulate that excellent stu-
dies should compare the performance of adapted to original measures
(Mokkink et al., 2016). We also recommend comparing the
Table 3
Collated evidence of measurement properties for each tool.
Measure Version Measurement properties Interpretability
Internal
Consistency
Reliability Content
validity
Structural
validity
Hypothesis
testing
Criterion
validity
Responsiveness Cross-
cultural
validity
Diﬀerences in scores
between groups
SBQ-R V2 +++ +++ + ++ Y
BSS − +++* ? +++ +/− +/− ++ Y
C-SSRS Self-report − +/−
Interview +/− +/− +++ ++ +++ ++ +
SITBI − +/− − ?
* denotes evidence from translated version only;? indeterminant evidence for or against a measurement property; +/− mixed evidence for and against a mea-
surement property; + consistent evidence in support of a measurement property (+ weak, ++ moderate, +++ strong evidence);− consistent evidence against a
measurement property (− weak, −− moderate, −−− strong evidence).
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performance of measures between ASC and general population groups,
to ascertain whether measurement properties of tools are similarly ro-
bust in autistic and non-autistic populations. For example, if a measure
designed for the general population does not adequately capture a
health outcome in ASC, then we would expect a diﬀerent factor struc-
ture, lower internal consistency, and criterion validity compared to the
general population, which should then improve for the adapted version
(see Cassidy, Bradley, Bowen, et al., 2018).
Out of the tools identiﬁed and evaluated in this review, the SBQ-R is
a free brief measure with only 4 questions, with comparable evidence in
support of a range of psychometric measures compared to longer and
more expensive tools (BSS and C-SSRS). It is therefore a promising
potential candidate tool to begin exploring suicidality in ASC in re-
search now, as an important stop gap before validated tools become
available. Items one and two of the SBQ-R focus on suicidal thoughts
and behaviours over one's lifetime and in the past year, with clear de-
ﬁnitions, e.g. “rarely (1 time)”. This could be potentially useful for
assessing presence of suicidal thoughts and behaviours in autistic
adults. However, items three and four will likely require adaptations for
autistic adults which importantly provide more information on risk
level. For example, autistic people's communication diﬃculties may
mean they are less likely to have had spontaneously communicated
their suicidal intent to others in the past (item three), despite high risk.
Additionally, literal interpretation and diﬃculties in imagination and
abstract future thinking in ASC may lead to diﬃculties interpreting and
responding to the ﬁnal question (item four) about likelihood of at-
tempting suicide in the future.
A crucial aspect of exploring validity of suicidality assessment tools,
are whether these are useful to clinicians in gauging risk of future
suicide attempts. However, few studies have explored this crucial as-
pect of criterion validity. Hence, it is critical that future studies asses-
sing criterion validity of suicidality assessment tools in autistic and
general populations not only rely on distinguishing sub-groups, which
over-estimate diagnostic accuracy of a tool. Rather, cohort studies are
needed to assess whether current and adapted suicidality assessment
tools can predict future suicidal behaviour signiﬁcantly more accurately
than clinician opinion or patient self-report.
6. Strengths and limitations
A key strength was using a rigorous method (COSMIN) to system-
atically identify and evaluate relevant studies. However, following this
strict method meant that some tools were excluded from the analysis,
such as single items or subscales from broader mental health measures.
As suicidality in ASC is such a new area of research, it could be argued
that adopting such rigorous methods might have led us to overlook
other relevant data which could indicate the usefulness of one tool over
another. However, we were interested in more speciﬁc and broader
conceptualisations of suicidality than is feasible in single questions or
subscales. We also focused on tools which had been used frequently in
general population adults, without ID, or co-occurring conditions, ra-
ther than including measures only used in psychiatric groups, as these
tools were more likely to be useful for a range of non-clinical and
clinical groups, and in a range of clinical and research contexts. Our
search was also limited by focusing only on studies in English, due to
lack of translation resources, and data extraction was also conducted
only in part by two independent reviewers. Although COSMIN is a
validated research tool, there is a certain level of subjectivity in rating
each article. However, there was good agreement between raters in the
current study (73%), similar to previous COSMIN reviews (e.g. Cassidy,
Bradley, Bowen, et al., 2018; Wigham & McConachie, 2014).
7. Conclusion
This is the ﬁrst systematic review to use a robust research tool
(COSMIN) to synthesise the evidence regarding the assessment of sui-
cidality in autistic and general population adults without ID. Although a
growing number of studies are beginning to assess suicidality in autistic
adults, none have yet used a validated suicidality assessment tool, and
there are currently no validated suicidality assessment tools available
for this group. Three robust suicidality assessment tools were identiﬁed
which have been used frequently in general population studies. Future
ASC studies must begin to use and explore the measurement properties
of such robust tools designed for the general population. Our research
group are currently undertaking this research in order to better char-
acterise suicidality and its measurement in ASC.
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Appendix A. Characteristics of suicidality tools identiﬁed in search one
Measure Version Year
published
Aim of tool Number
of items
Subscales Response
options
(e.g. 4
point
scale,
yes/no
etc.)
Format (e.g.
self-report
questionnaire,
interview etc.)
Used in which
references?
ASC Gen Pop
Columbia
Suicide
Severity
Rating Scale
(C-SSRS)
Interview
Self-
report
2011
2009
Measure of suicide
risk in research
and clinical
practise.
6
6
N/A Yes/No
Yes/No
Clinician
administered
interview
Self-report
questionnaire
N/
A
DeVylder et al
(2015)
Childress and
Berry (2010)
Measure of
episodic
planning of
suicide
(MEPOS)
V1 2014 Assesses
frequency and
characteristics of
prior suicide
attempts
4 N/A Yes/No
and single
response
follow up
questions
Self-report
questionnaire
N/
A
Anestis,
Pennings, and
Williams (2014)
Suicide
Behaviours
Questionnai-
re Revised
(SBQ-R)
V2 2001 Measure of suicide
risk
4 N/A 5/6 point
scales
Self-report
questionnaire
N/
A
Campose and
Holden (2014);
Campos, Besser,
and Blatt
(2013); Wagner,
Klinitzke,
Brähler, and
Kersting (2013).
Beck Scale for
Suicidal
Ideation
(BSS)
V2 1991 Assesses suicidal
ideation and
behaviours
21 1–19 current
suicidal
ideation, 20–21
past suicide
attempts
Yes/No
(check
this!)
Self-report
questionnaire
N/
A
van Spijker et al.
(2012); Van
Orden,
Cukrowicz,
Witte, and
Joiner Jr (2012);
Cleary, Nixon
and Fitzgerald,
(2007); Lane,
Cheref, and
Miranda (2016);
Zuromski, Cero,
Witte, and Zeng
(2017).
Beck Suicide
Intent
Inventory
V1 1974 Assesses risk of
suicidal attempts
in patients who
have attempted
suicide
15 1–8 objective
circumstances
surrounding
suicide attempt,
9–15 self-report
questions
surrounding
suicide attempt
Scale 1–3
options
Clinician
administered
and self-report
questionnaire
N/
A
Moran et al.
(2012).
Depression
Severity
Index –
Suicide
Subscale
(DSI-SS)
V1 1997 Identify frequency
and intensity of
current suicidal
ideation and
impulses in the
past 2 weeks
4 N/A Scale 1–4
options
Self-report
questionnaire
N/
A
Cukrowicz,
Smith,
Hohmeister, and
Joiner (2009).
Modiﬁed Scale
for Suicidal
Ideation
(MSSI)
V1 1986 Assess presence
and severity of
current suicidal
ideation in the
past 2 weeks.
18 N/A Scale 1–4
options
Self report
questionnaire
N/
A
Bagge, Lamis,
Nadorﬀ, and
Osman (2014).
Paykel V1 1974 5 N/A Scale 1–4 N/
A
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Assess lifetime
and current
experience of
suicidal ideation
and behaviours
Clinician
administered
interview or
self-report
questionnaire
Jonson, Skoog,
Marlow,
Fässberg, and
Waern (2012);
Rancāns, Lapiņš,
Renberg, and
Jacobsson
(2003);
Renberg,
(2001).
Sheehan
Suicidality
Tracking
Scale (S-STS)
V10 2009 Tracks
spontaneous and
treatment
emergent suicidal
ideation and
behaviours
8 Self-injury, self-
harm, suicidal
ideation and
suicide
attempts.
Yes/No or
scale 1–4
Clinician
administered or
self report
rating scale
N/
A
Preti et al.
(2013).
Suicide
Assessment
Scale (SUAS-
S)
V1 2006 Assesses signs and
symptoms related
to suicidality
20 N/A Scale 0–4 Self report
questionnaire
N/
A
Zhang et al.
(2012).
Suicide Ideation
Scale (SIS)
V1 1989 Measured a
continuum of
suicidal thoughts
and attempts in
clinical and non
clinical samples
10 N/A Scale 1–5 Self report
questionnaire
N/
A
Chu et al.
(2013).
Suicide Score
Scale (SSS)
V1 2008 Designed to
obtain
information about
life time and past
year previous
suicidal ideation,
planning or
attempts
12 N/A Yes/No Self report
questionnaire
N/
A
Innamorati et al.
(2008a).
Self-Injurious
Thoughts
and
Behaviours
Interview
(SITBI)
V1 2007 A structured
interview that
assesses the
presence,
frequency, and
characteristics of a
wide range of self-
injurious thoughts
and behaviours,
including suicidal
ideation, suicide
plans, suicide
gestures, suicide
attempts, and
non-suicidal self-
injury (NSSI).
169
items
across 5
modules
5 subscales: (a)
suicidal
ideation; (b)
suicide plans;
(c) suicide
gestures; (d)
suicide
attempts; and
(e) non-suicidal
self- injury.
Yes/No
and scales
1–4
Interview N/
A
Dhingra,
Boduszek, and
Klonsky (2016),
Mortier et al.
(2017a), Mortier
et al. (2017b).
Plutchik Suicide
Risk Scale
(PSRS)
V1 1989 Measures the
degree to which
an individual
reveals
characteristics
similar to those of
a suicide
prototype.
26 items N/A Yes/No Self-report N/
A
Pereira-Morales
et al. (2017).
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Appendix B. Characteristics of study populations included in the qualitative synthesis
Measure Article Study population/
sample
Study type
(prospective,
case-control
etc.)
Mean age (SD)
years; range
Total N Male n,
female n.
Country
SBQ-R Osman et al. (2001). Psychiatric patients
High school adolescent
Psychiatric patients
Undergraduate
Psychology student
Case-control 15.63/15.56
(0.98) 14–17 years
16.51/16.47
(1.33/1.14)
14–18 years
32.14/33.47
(7.43/8.79) age
range not reported
21.19/20.97
(2.98/2.91) age
range not reported
120
138
120
135
65 male, 55
female
72 male, 66
female
65 male, 55
female
69 male, 66
female
US
SBQ-R Aloba et al. (2017). Adult undergraduate
students
Cross-sectional 22.51 (2.94)
18–31 years
536 272 (50.7%)
male, 263
(49.3%) female
Nigeria
BSS de Beurs et al. (2016). Psychiatric patients Longitudinal 33/38 (13.2/13.8)
age range not
provided
366 158 male, 208
female
UK
BSS Esfahani et al. (2015). General population Cross-sectional 27 (9.5)
18–70 years
535 138 male, 397
female
Tehran
BSS / C-
SSRS
(self
re-
port)
Chang and Tan (2015). Psychiatric patients Prospective 36.4 age range
20–47 years
50 22 male, 28
female
US
BSS de Beurs et al. (2015). Psychiatric patients Longitudinal 43 (15) age range
not provided
872 (at
baseline)
415 male, 457
female
Netherlands
BSS Horon, McManus,
Schmollinger, Barr, and
Jimenez (2013).
Psychiatric Patients Cross- sectional 37, age range
19–75
342 342 male US
BSS Ayub (2008). General population
adolescents and young
adults
Cross-sectional 20.06, (2.39)
17–25 years.
904 442 female Pakistan
BSS Chioqueta and Stiles
(2006).
University students Cross-sectional 21.46 (3.63)
17–44 years.
314 71 male, 243
female
Norway
BSS Healy et al. (2006) Psychiatric patients Cross-sectional 37.51 (13.52),
18–37 years.
735 319 male, 413
female
US
BSS Holden and DeLisle
(2005).
Psychology students and
community sample
suicide attempters
Cross-sectional 24.39 (11.47),
17–68 years.
134 15 male, 119
female
Canada
BSS Pinninti et al. (2002). Psychiatric patients Cross-sectional 41.68 (4.91), age
18+
130 64 male, 66
female
US
BSS Cochrane-Brink et al.
(2000).
Psychiatric patients Cross-sectional 34.7 (10.9), age
18+
55 31 male, 24
female
Canada
BSS Steer et al. (1993). Psychiatric patients Cross-sectional 38.28 (14.14), age
range not provided
330 154 male, 176
female
US
BSS Kliem et al. (2017). General population
adults identiﬁed as high
suicide risk on BSS
Cross-sectional 49.7 (17.83), age
18+
112 53% male Germany
C-SSRS Madan et al. (2016). Inpatient cohort of
mentally ill adults
Prospective 35.2 (+/−
14.7 years)
1055 540 male, 515
female
US
C-SSRS Al-Halabi et al. (2016). Psychiatric patients Cross-sectional 46.93 467 Not speciﬁed Spain
C-SSRS Youngstrom et al.
(2015).
Adult inpatients Cross-sectional 38.5 (+/−
12.4 years)
199 57% female US
S.A. Cassidy et al. Clinical Psychology Review 62 (2018) 56–70
67
C-SSRS Viguera et al. (2015). Psychiatric patients Cross-sectional 43.7 (+/−
14.9 years), age
range 18–94 years
1416 533 male, 883
female
US
C-SSRS Sheehan et al. (2014). Adults with self-injurious
behaviour
Cross sectional 39.9 (15), age
range 19–73 years
40 44.4% male US
C-SSRS Horwitz et al. (2015). Psychiatric patients Longitudinal 19.38 (2.9), age
range 15–24 years.
473 220 male, 253
female
US
C-SSRS Mundt et al. (2010). Clinical samples from
treatment trials
Prospective Not reported 3776 Not reported US
C-SSRS Hesdorﬀer et al.
(2013).
Treatment resistant focal
epilepsy
Cross-sectional 41.2 (31.2), age
range 18–70 years
208 71 male, 137
female
US
C-SSRS Mundt et al. (2010). Psychiatric patients
General population
controls
Case-control 30.9 years, age
range 18–57 years
32.9 year, age
range 24–40 years
10
10
4 male, 6
female
1 male, 9
female
US
C-SSRS Posner et al. (2011). Adolescent suicide
attempters
Depressed adolescents
Psychiatric patients
Treatment study
Medication
eﬃcacy trial –
longitudinal
Cross sectional
study
12–18 years
11–17 years
Over 18 years
124
312
237
US
SITBI Garcia-Nieto et al.
(2013).
Psychiatric patients Cross sectional 43.3 years (10.3),
no age range given
150 84 (56) female Spain
Appendix C
Supplementary data to this article can be found online at https://doi.org/10.1016/j.cpr.2018.05.002.
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